Login
$JNJ
$282.90 +$0.35 (0.12%) After hours

$JNJ 8-K/A SEC Filings

Filed On Filing
22 Jan 2025 8-K/A: Financial Statements and Exhibits

New Brunswick, N.J. (January 22, 2025) – Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2024. "2024 was a transformative year for Johnson & Johnson, marked by strong growth, an accelerating pipelin...

16 Apr 2024 8-K/A: Financial Statements and Exhibits

New Brunswick, N.J. (April 16, 2024) – Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2024. “Johnson & Johnson’s solid first quarter performance reflects our sharpened focus and the progress in our portfolio and ...

15 Feb 2023 8-K/A: Departure/Election of Directors or Officers; Compensation

Johnson & Johnson Names Paula A. Johnson, President of Wellesley College, to its Board of Directors New Brunswick, NJ (February 14, 2023) – Johnson & Johnson (NYSE: JNJ) announced today that Paula A. Johnson, MD, MPH, President of Welles...

29 Aug 2017 8-K/A: Completion of Acquisition or Disposition of Assets

2Excludes amortization of intangible assets as presented separately.

04 Aug 2008 8-K/A: Results of Operations and Financial Condition

On July 15, 2008, Johnson & Johnson issued the attached press release announcing its sales and earnings for the second quarter ended June 29, 2008. (Explanatory Note: The press release is incorporated by reference to Exhibit 99.15 of the...

30 Nov 2007 8-K/A: Material Impairments; Other Events

On November 29, 2007, Johnson & Johnson (the "Company") announced that it will record a special after-tax, non-cash charge of approximately $440 million for the write-down of the intangible asset related to NATRECORr (nesiritide), a prod...

02 Mar 2007 8-K/A: Completion of Acquisition or Disposition of Assets

COMBINED FINANCIAL STATEMENTS AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2005 AND 2004 AND INDEPENDENT AUDITORS' REPORT THEREON

30 Apr 2002 8-K/A: Other Events

2001 2000 1999 1998 1997 1996 Sales to customer- Domestic 19,825 17,316 15,532 12,901 11,814 10,851 Sales to customer- Int'l 12,492 11,856 11,825 10,910 10,708 10,536 Total Sales 32,317 29,172 27,357 23,811 22,522 21,387 Cost of products...

30 Nov 2001 8-K/A: Other Events

Johnson & Johnson Completes Acquisition Of Inverness Medical Technology's Diabetes Care Products Business ---------------------------------------

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support